Understanding the pathogenesis of the SARS-CoV-2 infection is key to developing preventive and therapeutic strategies against COVID-19, in the case of severe illness but also when the disease is mild. The use of appropriate experimental animal models remains central in the in vivo exploration of the physiopathology of infection and antiviral strategies. This study describes SARS-CoV-2 intranasal infection in ferrets and hamsters with low doses of low-passage SARS-CoV-2 clinical French isolate UCN19, describing infection levels, excretion, immune responses and pathological patterns in both animal species. Individual infection with 103 p.f.u. SARS-CoV-2 induced a more severe disease in hamsters than in ferrets. Viral RNA was detected in the lungs of hamsters but not of ferrets and in the brain (olfactory bulb and/or medulla oblongata) of both species. Overall, the clinical disease remained mild, with serological responses detected from 7 days and 10 days post-inoculation in hamsters and ferrets respectively. The virus became undetectable and pathology resolved within 14 days. The kinetics and levels of infection can be used in ferrets and hamsters as experimental models for understanding the pathogenicity of SARS-CoV-2, and testing the protective effect of drugs.
This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. The Microbiology Society waived the open access fees for this article.
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol2020; 5:536–544
RockxB,
KuikenT,
HerfstS,
BestebroerT,
LamersMM et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science2020; 368:1012–1015 [View Article]
ChanJF-W,
ZhangAJ,
YuanS,
PoonVK-M,
ChanCC-S et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis2020
RyanKA,
BewleyKR,
FotheringhamSA,
BrownP,
HallY.
Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge [Internet]. Microbiology2020
ShiJ,
WenZ,
ZhongG,
YangH,
WangC et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science2020; 368:1016–1020 [View Article]
ImaiM,
Iwatsuki-HorimotoK,
HattaM,
LoeberS,
HalfmannPJ et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci USA2020; 117:16587–16595
European Commission Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes; European Commission.
Journal Officiel de la République FrançaiseDécret n 2013-118 Du 1er Février 2013 Relatif La Protection des Animaux Utilisés Des Fins Scientifiques Paris, France: 2013 p 2199
ChrunT,
LacôteS,
UrienC,
JouneauL,
BarcC et al. A Rift Valley fever virus GN ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting. NPJ Vaccines2018; 3:14 [View Article]
BrycheB,
St AlbinA,
MurriS,
LacôteS,
PulidoC et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun2020; 89:579586 [View Article][PubMed]
EdlerC,
SchröderAS,
AepfelbacherM,
FitzekA,
HeinemannA,
HeinrichF et al. Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med2020; 134:1275–1284 [View Article]
SchaeferI-M,
PaderaRF,
SolomonIH,
KanjilalS,
HammerMM et al. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19. Mod Pathol2020
MartinesRB,
RitterJM,
MatkovicE,
GaryJ,
BollwegBC et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerging Infect Dis. 21 mai2020; 26:
PetrilliCM,
JonesSA,
YangJ,
RajagopalanH,
O’DonnellL et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ2020; 2:m1966 [View Article]
NikpouraghdamM,
Jalali FarahaniA,
AlishiriG,
HeydariS,
EbrahimniaM et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in Iran: a single center study. J Clin Virol2020; 127:104378 [View Article]
LuoH,
LieY,
PrinzenFW.
Surveillance of COVID-19 in the general population using an online questionnaire: report from 18,161 Respondents in China. JMIR Public Health Surveill2020; 6:e18576 [View Article]
RehmanS,
MajeedT,
Azam AnsariM,
AliU,
SabitH et al. Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi J Biol Sci2020; 15 mai:
LiuY,
PangY,
HuZ,
WuM,
WangC et al. Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells. Clin Infect Dis2020; 22 mai: